Fresh2 Group Limited (NASDAQ:FRES – Get Free Report) was the recipient of a large growth in short interest in September. As of September 30th, there was short interest totalling 17,200 shares, a growth of 437.5% from the September 15th total of 3,200 shares. Based on an average trading volume of 36,900 shares, the days-to-cover ratio is presently 0.5 days.
Analyst Upgrades and Downgrades
Separately, Canaccord Genuity Group upgraded shares of Fresh2 Group to a “strong-buy” rating in a research note on Thursday, August 8th.
Get Our Latest Stock Report on Fresh2 Group
Fresh2 Group Trading Up 10.6 %
About Fresh2 Group
Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People’s Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc.
Further Reading
- Five stocks we like better than Fresh2 Group
- How to Calculate Options Profits
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
- Are Penny Stocks a Good Fit for Your Portfolio?
- China’s EV Rally: Should Investors Chase, Avoid, or Buy the Dip?
- Industrial Products Stocks Investing
- MarketBeat Week in Review – 10/7 – 10/11
Receive News & Ratings for Fresh2 Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresh2 Group and related companies with MarketBeat.com's FREE daily email newsletter.